The Food and Drug Administration (FDA) on Monday granted full approval to Pfizer’s COVID-19 vaccine for individuals 16 years and older.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic,” Acting FDA Commissioner Janet Woodcock said in a statement issued Monday. “While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product.”

FULL FDA APPROVAL FOR COVID-19 VACCINES COULD EASE VACCINE HESITANCY: EXPERT

COVID-19 vaccines developed by Pfizer, Moderna and Johnson & Johnson have all previously been granted emergency use authorization (EUA) after meeting the FDA’s safety and…

Read more…

Share.

Comments are closed.